{
    "code": "06021675",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=06021675",
    "time": "2020-09-18 04:35:35",
    "許可證字號": "衛署醫器輸字第021675號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "QSD6639",
    "有效日期": "114\/11\/02",
    "發證日期": "99\/11\/02",
    "許可證種類": "醫　器",
    "舊證字號": "",
    "醫療器材級數": "第二等級",
    "通關簽審文件編號": "DHA00602167506",
    "中文品名": "美帝亞斯非梅毒螺旋菌脂質抗體試劑",
    "英文品名": "Mediace RPR",
    "效能": "測量血清或血漿中的梅毒抗血脂抗體。",
    "醫器規格": "455025: Mediace RPR (A) Buffer 18ML*2\/ Latex Suspension 12ML*1455032: Mediace RPR (M) Buffer 60ML*1\/ Latex Suspension 20ML*1455049: Mediace RPR (H) Buffer 180ML*1\/ Latex Suspension 60ML*1455353: RPR Standard Serum 1ML*5conc.*1455360: RPR Control (Negative\/ Positive)1ML*2conc.*2 \r\n增加規格：詳如中文仿單核定本（原99年11月16日核定之仿單標籤核定本予以作廢）。註銷規格：455049: Mediace RPR (H) Buffer 180ML*1\/Laxtex Suspension 60ML*1。\r\n新增規格：512353。註銷規格：467264（原104年1月30日仿單標籤核定本正本收回作廢）。",
    "劑型": "",
    "包裝": "",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "醫器主類別一": "C免疫學及微生物學裝置",
    "醫器次類別一": "C3820梅毒螺旋體非螺旋體試劑",
    "醫器主類別二": "",
    "醫器次類別二": "",
    "醫器主類別三": "",
    "醫器次類別三": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "",
    "限制項目": "02輸　入",
    "申請商名稱": "0415601100  元英企業股份有限公司",
    "申請商地址": "台北市內湖區陽光街365巷37號6樓",
    "主製造廠": [
        {
            "製造廠名稱": "MJP0398000  Sekisui Medical Co., Ltd Tsukuba Plant",
            "製造廠廠址": "3-1, Koyodai 3-chome Ryugasaki-shi, Ibaraki, 301-0852, Japan",
            "製造廠公司地址": "",
            "製造廠國別": "JAPAN",
            "製程": ""
        }
    ],
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "060216750002-106-06-22.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=06021675&Seq=003&Type=9"
        },
        {
            "title": "060216750002-106-06-22.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=06021675&Seq=003&Type=8"
        }
    ]
}